uniQure CEO exercises options, sells 21,082 shares
uniQure N.V.’s CEO Matthew C. Kapusta exercised stock options and sold shares in a pre-planned trade.
Rhea-AI Filing Summary
uniQure N.V.’s CEO Matthew C. Kapusta exercised stock options and sold shares in a pre-planned trade. On July 2, 2026, he exercised options for 21,082 Ordinary Shares at an exercise price of $19.39 per share and converted them into common equity.
That same day, he sold 21,082 Ordinary Shares in three open-market transactions at reported weighted average prices of $44.43, $45.43, and $45.89, with actual sale prices ranging from $44.10 to $46.10. Following these transactions, he directly owned 519,227 Ordinary Shares. The filing states the trades were executed under a Rule 10b5-1 sales plan adopted on October 5, 2025, indicating they were pre-scheduled.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 21,082 shares ($543K approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Kapusta Matthew C
Role
CEO, Managing Director
Sold
21,082 shs ($952K)
Approx. gross sale proceeds
$952K
Approx. exercise cost
$409K
Approx. pre-tax spread
$543K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 21,082 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 21,082 | $19.39 | $409K |
| Sale | Ordinary Shares | 9,200 | $44.43 | $409K |
| Sale | Ordinary Shares | 4,282 | $45.43 | $195K |
| Sale | Ordinary Shares | 7,600 | $45.89 | $349K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Ordinary Shares — 519,227 shares (Direct)
Footnotes (5)
- F1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The Stock Option vested in full on January 26, 2022.
Key Figures
Shares sold: 21,082 shares
Sale prices (weighted averages): $44.43, $45.43, $45.89 per share
Sale price range: $44.10–$46.10 per share
+5 more
8 metrics
Shares sold
21,082 shares
Total Ordinary Shares sold on July 2, 2026
Sale prices (weighted averages)
$44.43, $45.43, $45.89 per share
Three open-market sale tranches on July 2, 2026
Sale price range
$44.10–$46.10 per share
Price ranges disclosed for multiple sale transactions
Option exercise size
21,082 shares
Ordinary Shares acquired via stock option exercise
Option exercise price
$19.39 per share
Exercise price of Stock Option converted on July 2, 2026
Post-transaction holdings
519,227 shares
Ordinary Shares directly owned after reported transactions
Option expiration
January 26, 2028
Expiration date of Stock Option that was exercised
Option vesting date
January 26, 2022
Date the Stock Option vested in full
Key Terms
Rule 10b5-1, weighted average price, Stock Option (Right to Buy), open-market sale, +2 more
6 terms
Rule 10b5-1 regulatory
"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What did uniQure (QURE) CEO Matthew Kapusta report in this Form 4?
He reported exercising stock options for 21,082 Ordinary Shares at $19.39 per share and selling 21,082 shares in three open-market trades on July 2, 2026. After these transactions, he directly held 519,227 Ordinary Shares.
What stock option activity did the uniQure (QURE) CEO report?
He exercised a Stock Option for 21,082 Ordinary Shares at an exercise price of $19.39 per share. The option, which vested in full on January 26, 2022, was fully exercised, and the derivative position in that option dropped to zero.
What does the weighted average price disclosure mean in this QURE Form 4?
The filing reports weighted average sale prices because shares were sold in multiple trades at different prices within specified ranges. It notes individual sale prices ranged from $44.10 to $46.10, and offers to provide exact breakdowns upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
